GSK And Pfizer Assemble Consumer Healthcare Leadership Team As JV Closes
Executive Summary
Under Brian McNamara’s leadership, GSK Consumer Healthcare has begun to assemble a management team that combines talent from both GSK and Pfizer.
You may also be interested in...
McNamara To Lead GSK’s Standalone Consumer Healthcare Business
Following a six month selection process, GSK has named Brian McNamara as CEO designate of its standalone Consumer Healthcare business, which will list on the London Stock Exchange next year.
GSK To Spin Off And List Consumer Healthcare Business In 2022
GSK will demerge its Consumer Healthcare business in mid-2022 and list the new company on the London Stock Exchange. The move will “create new world leader in consumer healthcare,” according to GSK, with annual sales in excess of £10bn.
GSK Consumer Separation On Track For Summer '22
COVID-19 has not held back GSK's preparations to create the world's largest standalone consumer health business, with CEO Emma Walmsley confirming separation is on track for summer next year.